Learn More
Medchemexpress LLC GSK215 | 2743427-26-9 | 99.3% | C50H59F3N10O6S | 10MG

Supplier: Medchemexpress LLC HY13229610MG
GSK215 is a research-use PROTAC that selectively degrades focal adhesion kinase (FAK) by recruiting the VHL E3 ligase. It exhibits high potency (pDC50 ≈ 8.4) and causes rapid, prolonged reduction of FAK levels in cellular assays, making it useful for probing FAK-dependent signaling and pharmacology. Not for human or clinical use.
- Selective FAK degradation via VHL E3 ligase.
- High potency (pDC50 ≈ 8.4).
- Rapid and sustained target knockdown in cells.
- Supplied as a high-purity research compound.
- Available in multiple milligram pack sizes for screening.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.